Home › Funds › Maple Rock Capital Partners Inc. › CVS

Maple Rock Capital Partners Inc. position in CVS

CVS HEALTH CORP · Consumer Staples

Maple Rock Capital Partners Inc. reported holding 1,197,996 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$123.9M, representing 2.43% of its reported portfolio and ranking #13 among its reported holdings. Maple Rock Capital Partners Inc. has disclosed CVS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.20M sh
Reported value held$123.93M
Portfolio Weight2.43%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Maple Rock Capital Partners Inc.'s CVS position evolved

Maple Rock Capital Partners Inc. first disclosed a stake in CVS in Q4 2025 at 816,400 shares (US$64.8M). The position peaked in Q2 2026 at 1,197,996 shares, worth US$123.9M. Across 3 filings, Maple Rock Capital Partners Inc. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,197,996 shares valued at US$123.9M — an increase of 149,896 shares quarter over quarter.. Notable position changes include a 28% increase in Q1 2026 (shares rose 45% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 816.40K $64.79M New
Q1 2026 1.05M $75.27M Add
Q2 2026 1.20M $123.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has Maple Rock Capital Partners Inc. held CVS?

Maple Rock Capital Partners Inc. has disclosed CVS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Maple Rock Capital Partners Inc.'s current position in CVS?

As of Q2 2026, Maple Rock Capital Partners Inc. holds 1.20M shares of CVS (CVS HEALTH CORP), valued at $123.93M, representing 2.43% of its reported portfolio and ranking #13.

Has Maple Rock Capital Partners Inc. been buying or selling CVS?

In the latest 13F filing (Q2 2026), Maple Rock Capital Partners Inc. increased its position in CVS. The position peaked in Q2 2026 at 1.20M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.